Wendy C. Goldstein, J.D., M.P.H., is an experienced health care regulatory and enforcement defense attorney with over 25 years of expertise in the health care and life sciences ecosystem. Her clients included biopharmaceutical and device manufacturers, payors, pharmacy benefit managers, providers including hospital systems, digital health companies, medical technology companies and other ancillary providers in the health care and life sciences space. She also represented private equity and other entities investing in those sectors.
Wendy C. Goldstein is currently serving as Special Counsel to the NYS Commissioner of Health as an appointment by Governor Andrew Cuomo. She was chair of Cooley LLP’s life sciences and health care regulatory practice through February 2020. Prior to joining Cooley in 2013, Wendy served as a partner in the New York office of Epstein, Becker and Green, P.C. where she was a member of the Board of Directors, chair of the firm’s Health Care and Life Sciences Practice Steering Committee and the Pharmaceutical Industry Health Regulatory Practice Group.
Wendy speaks and writes extensively on issues relating to health care regulatory and policy matters including fraud and abuse, board governance, government pharmaceutical program pricing, corporate compliance, government enforcement activity relevant to the life sciences and managed care industries and health care reform. She was a contributing author to the ABA Health Law Section Pharmaceutical Law treatise. Wendy authored Chapter 8: Federal and State Regulation and Enforcement of Pharmaceutical Manufacturers’ Advertising and Promotional Activity in the 2016, 2015 and 2014 Practicing Law Institute Pharmaceutical Compliance and Enforcement Answer Book. She has served as an adjunct professor of health care fraud and abuse at Pace University School of Law. Wendy also has served on several advisory boards for industry publications and legal associations including the New York State Bar Association Committee on Medical Research and Biotechnology and the New York City Bar Committee on Bioethical Issues.
Wendy serves on the Advisory Boards and a Board of Directors of several non-profit health care associations and educational institutions. She also is actively involved in pro bono activities relating to the pediatric oncology research and other health care education and access initiatives.
Wendy has been selected for inclusion in The Best Lawyers in America (2013-2020). She was also selected by Crain’s New York Business as one of the Leading Women Lawyers in New York City (2018). She has been ranked by Chambers USA as one of America’s leading lawyers for healthcare (2008-2019). Wendy was recognized as a leading lawyer in the 2017 Legal 500 United States, for Healthcare Life Sciences. She was recognized as a Life Science Star in LMG Life Sciences in 2012, 2013 and 2015 and was named by LMG as “Attorney of the Year” for Healthcare Pricing and Reimbursement in 2013. Wendy has been consistently named by the New York Super Lawyers – Metro (2006-2020), which cited her among its “Top 100” (2010- 2020) and its “Top 50 Women” (2006, 2007, and 2009-2020). She was named as one of Nightingale’s Outstanding Young Healthcare Lawyers in 2007.